Views & Analysis Could the PPRS support a changing growth and innovation agen... Has the PPRS delivered on the aim to support the government’s growth and innovation agenda?
News After setback, Rhythm gets good news on Imcivree from FDA Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
